USPTO serial 77532499
GENFIT TOWARDS BETTER MEDICINE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 11, 2010
- Examiner
- RINKER, ANTHONY MICHAEL
- Law office
- GENERIC WEB UPDATE
What this means
Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection. Calendar the next Section 8 and 9 deadline in 10 years and maintain monitoring.
Need help with GENFIT TOWARDS BETTER MEDICINE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brooks R. Bruneau
Brooks R. Bruneau FisherBroyles, LLP100 Overlook CenterSecond FloorPRINCETON, NJ 08540Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | [ Enzymatic preparations for scientific and research purposes in the medical, or pharmaceutical fields ] | SECTION 8 - CANCELLED | — |
| 005 | [ Pharmaceutical products for the treatment of cardiovascular diseases, dermatological diseases, disorders in the central nervous system, cancers, asthma, allergies, lipidic disorders, obesity and diabetes; sanitary preparations for medical use; biological preparations for medical use; slimming medical preparations, namely, diet pills, tablets, sachets of powder, capsules, syrups; cultures of microorganisms for medical, pharmaceutical or veterinary use; culture media for use in bacteriology; cell culture preparations of eucaryotic cell lines or microorganisms for medical or pharmaceutical use, in particular in gene therapy and cell therapy; biologically active compounds being components of pharmaceutical preparations for treating metabolic disorders in human beings and animals, in particular in the case of cardiovascular diseases, dermatological diseases, disorders in the central nervous system, cancers, asthma, allergies, lipidic disorders, obesity and diabetes; kits comprising cells, nucleic acids, proteins or reagents for the preparation or the selection of biologically active compounds or cells for medical purposes; diagnostic preparations for medical use comprising chemical reagents for in-vivo, ex-vivo or in-vitro use; diagnosis reagents for medical or veterinary use; sanitary preparations for medical use; dietetic substances for medical use; dietetic foodstuffs for medical use; food supplements for medical use; enzyme preparations for medical or veterinary use, namely, enzyme food supplements and animal feed additives in the nature of enzymes for use in animal feeds to assist in digestion ] | SECTION 8 - CANCELLED | — |
| 042 | Pharmaceutical research for the discovery of new drugs; scientific research, in particular in the medical, biomedical, chemical, genetic, pharmaceutical [ or veterinary ] fields; basic and applied research in the medical field; [ technical research in the scientific field; ] pharmaceutical research for the screening and selection of molecules for drug development; scientific research for the development and validation of biological tests, of cell tests and of genetic tests; [ development of new technology for others in the field of functional genomics to identity, characterize, validate or develop biologically active molecules; ] biological research via analysis of biological substances in biologic fluids [ ; computer programming in the field of scientific research and for the pharmaceutical industry; analysis of technical medical products or processes for scientific and research purposes in the medical, pharmaceutical or biotechnological fields; professional consultancy, not connected with the conduct of business, in the fields of scientific research and for the pharmaceutical industry; research and development of new pharmaceutical products for third parties; rental of computer hardware, namely, access time to a scientific data base server centre ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Genfit
- Other trademarks owned by Genfit
- Other trademarks owned by Genfit
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named GENFIT TOWARDS BETTER MEDICINE
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 29, 2020 | NA89 | NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED | — |
| Jun 29, 2020 | RNL1 | REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS) | The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active. |
| Jun 29, 2020 | 89AG | REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED | The USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary. |
| Jun 29, 2020 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 17, 2020 | E89R | TEAS SECTION 8 & 9 RECEIVED | — |
| May 11, 2019 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Jul 6, 2016 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Jul 6, 2016 | C15P | REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Jul 5, 2016 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 10, 2016 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| May 11, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 23, 2010 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 23, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 15, 2010 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 14, 2010 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 23, 2009 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Dec 23, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 17, 2009 | PAPER RECEIVED | — | |
| Jun 15, 2009 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 2009 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 2009 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 23, 2009 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| May 23, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 18, 2009 | ALIE | ASSIGNED TO LIE | — |
| May 15, 2009 | PAPER RECEIVED | — | |
| Nov 13, 2008 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 13, 2008 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 13, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 5, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 1, 2008 | MDSC | NOTICE OF DESIGN SEARCH CODE MAILED | — |
| Jul 31, 2008 | NWAP | NEW APPLICATION ENTERED | — |